Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Travelers Companies (The) (TRV)
NYSEFinancialsInsurance - Property & CasualtySnapshot 2026-11-04
$409.25+3.50%
Close 2026-11-04 · 1-day change
NYSEFinancialsInsurance - Property & CasualtySnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
30.36 → 31.02 EPS · FY ending Dec 31, 2027 · 17 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 17 to 17; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for TRV yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Return at least $2.2 billion to shareholders in Q1 2026 | Profit margins and capital return stay solid. | Intact | Capital returned falls below $2.2 billion in Q1 2026 | Required source inputs unavailable Cannot calculate Cash returned to shareholders from the available matching source inputs. Missing inputs are not treated as zero. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 3 of 8 supplied quarters. Management reported: “The Board of Directors declared a 14% increase in the regular quarterly dividend to $1.25 per share.” “In recognition of our strong financial position and confidence in the outlook for our business, I am pleased to share that our Board of Directors declared a 5% increase in our quarterly cash dividend to $1.10 per share, marking 21 consecutive years of dividend increases with a compound annual growth rate of 8% over that period.” |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a mature insurance business with a multi-year view tied to disciplined underwriting and steady capital returns. The thesis is intact, and recent performance is strong, though execution across key priorities is mixed.
The valuation is tagged as stretched, despite being described as cheap in the broad value factor, so the evidence is mixed on how it compares with peers. The model points to a durable premium, with an expectations gap of 0.19; confidence in that valuation estimate is medium. Fragility is low, meaning no listed warning signals point to concentrated valuation risk.
Recent results were strong, with an October earnings beat and the combined ratio improving to 86.8% from 87.3% a year earlier; the ratio measures claims and expenses against premiums, so a lower figure indicates better reported underwriting results. Revenue was slightly lower over the same comparison, making delivery mixed, while capital returns remain on track. Near-term miss risk is low, but recent earnings have been erratic, and guidance changes or rate cuts are risks to watch.
Over the next few quarters, the thesis depends on continued underwriting discipline, progress toward the expense-ratio expectation, and guidance that does not weaken. Lower interest rates could weigh on the insurance sector, while continued strong results and higher guidance from sector peers could support sector momentum. The multi-year view also depends on capital returns continuing alongside operating performance.
For the next 1 to 3 years, TRV has an intact thesis backed by strong recent performance and capital returns, but mixed execution and stretched valuation expectations leave meaningful questions around consistency. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Core income grows to at least $1.7 billion in Q1 2026 | Travelers grows core income strongly, reaching $1.7 billion in Q1 2026. | Intact | Core income falls below $1.7 billion in Q1 2026 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Expense ratio stays near 28.5% for full year 2026 | The company aims to keep expense ratio near 28.5% in 2026. | Under Pressure | Expense ratio rises above 29% for FY26 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$30.00 → $31.02 · observed estimates
$45.23B → $44.85B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $30.00 | $45,231,376,115 | 17 / 12 |
| 2026-07-25 | $30.04 | $44,671,354,840 | 27 / 14 |
| 2026-07-26 | $30.04 | $44,671,354,840 | 27 / 14 |
| 2026-07-27 | $30.11 | $44,699,000,000 | 27 / 12 |
| 2026-07-28 | $30.17 | $45,239,328,124 | 17 / 11 |
| 2026-07-29 | $30.17 | $45,239,328,124 | 17 / 11 |
| 2026-07-30 | $30.16 | $44,685,032,380 | 27 / 13 |
| 2026-07-31 | $30.16 | $44,685,032,380 | 27 / 13 |
| 2026-08-01 | $30.23 | $45,267,055,291 | 17 / 12 |
| 2026-08-02 | $30.16 | $44,685,032,380 | 27 / 13 |
| 2026-08-03 | $30.16 | $44,685,032,380 | 27 / 13 |
| 2026-08-04 | $30.23 | $45,267,055,291 | 17 / 12 |
| 2026-08-05 | $30.22 | $44,678,109,310 | 27 / 13 |
| 2026-08-06 | $30.23 | $45,267,055,291 | 17 / 12 |
| 2026-08-08 | $30.23 | $45,267,055,291 | 17 / 12 |
| 2026-08-09 | $30.23 | $45,267,055,291 | 17 / 12 |
| 2026-08-10 | $30.23 | $45,267,055,291 | 17 / 12 |
| 2026-08-12 | $30.21 | $44,697,285,080 | 27 / 12 |
| 2026-08-13 | $30.23 | $45,267,055,291 | 17 / 12 |
| 2026-08-14 | $30.23 | $45,267,055,291 | 17 / 12 |
| 2026-08-15 | $30.23 | $45,267,055,291 | 17 / 12 |
| 2026-08-16 | $30.23 | $45,267,055,291 | 17 / 11 |
| 2026-08-17 | $30.23 | $45,267,055,291 | 17 / 11 |
| 2026-08-18 | $30.23 | $45,267,055,291 | 17 / 11 |
| 2026-08-19 | $30.23 | $45,267,055,291 | 17 / 11 |
| 2026-08-20 | $30.25 | $45,240,694,199 | 17 / 11 |
| 2026-08-21 | $30.25 | $45,240,694,199 | 17 / 11 |
| 2026-08-22 | $30.25 | $45,240,694,199 | 17 / 11 |
| 2026-08-23 | $30.25 | $45,240,694,199 | 17 / 11 |
| 2026-08-24 | $30.25 | $45,240,694,199 | 17 / 11 |
| 2026-08-25 | $30.25 | $45,240,694,199 | 17 / 11 |
| 2026-08-26 | $30.25 | $45,240,694,199 | 17 / 11 |
| 2026-08-27 | $30.25 | $45,240,694,199 | 17 / 11 |
| 2026-08-28 | $30.25 | $45,240,694,199 | 17 / 11 |
| 2026-08-29 | $30.25 | $45,240,694,199 | 17 / 11 |
| 2026-08-30 | $30.25 | $45,240,694,199 | 17 / 11 |
| 2026-08-31 | $30.25 | $45,240,694,199 | 17 / 11 |
| 2026-09-01 | $30.25 | $45,240,694,199 | 17 / 11 |
| 2026-09-02 | $30.25 | $45,240,694,199 | 17 / 11 |
| 2026-09-03 | $30.25 | $45,240,694,199 | 17 / 11 |
| 2026-09-04 | $30.25 | $45,240,694,199 | 17 / 11 |
| 2026-09-05 | $30.25 | $45,240,694,199 | 17 / 11 |
| 2026-09-06 | $30.25 | $45,240,694,199 | 17 / 11 |
| 2026-09-07 | $30.25 | $45,240,694,199 | 17 / 11 |
| 2026-09-08 | $30.25 | $45,240,694,199 | 17 / 11 |
| 2026-09-09 | $30.25 | $45,240,694,199 | 17 / 11 |
| 2026-09-10 | $30.25 | $45,240,694,199 | 17 / 11 |
| 2026-09-11 | $30.25 | $45,240,694,199 | 17 / 11 |
| 2026-09-12 | $30.25 | $45,240,694,199 | 17 / 11 |
| 2026-09-13 | $30.25 | $45,240,694,199 | 17 / 11 |
| 2026-09-14 | $30.25 | $45,240,694,199 | 17 / 11 |
| 2026-09-15 | $30.25 | $45,240,694,199 | 17 / 11 |
| 2026-09-16 | $30.25 | $45,240,694,199 | 17 / 11 |
| 2026-09-17 | $30.27 | $45,240,694,199 | 17 / 11 |
| 2026-09-18 | $30.27 | $45,240,694,199 | 17 / 11 |
| 2026-09-19 | $30.27 | $45,240,694,199 | 17 / 11 |
| 2026-09-20 | $30.27 | $45,240,694,199 | 17 / 11 |
| 2026-09-21 | $30.27 | $45,240,694,199 | 17 / 11 |
| 2026-09-22 | $30.29 | $45,240,694,199 | 17 / 11 |
| 2026-09-23 | $30.29 | $45,240,694,199 | 17 / 11 |
| 2026-09-24 | $30.31 | $45,301,337,056 | 17 / 11 |
| 2026-09-25 | $30.31 | $45,301,337,056 | 17 / 12 |
| 2026-09-26 | $30.31 | $45,301,337,056 | 17 / 12 |
| 2026-09-27 | $30.31 | $45,301,337,056 | 17 / 12 |
| 2026-09-28 | $30.31 | $45,301,337,056 | 17 / 12 |
| 2026-09-29 | $30.31 | $45,301,337,056 | 17 / 12 |
| 2026-09-30 | $30.31 | $45,301,337,056 | 17 / 12 |
| 2026-10-01 | $30.31 | $45,301,337,056 | 17 / 12 |
| 2026-10-02 | $30.36 | $45,301,337,056 | 17 / 12 |
| 2026-10-03 | $30.36 | $45,301,364,163 | 17 / 11 |
| 2026-10-04 | $30.36 | $45,301,364,163 | 17 / 11 |
| 2026-10-05 | $30.36 | $45,301,364,163 | 17 / 11 |
| 2026-10-06 | $30.36 | $45,301,364,163 | 17 / 11 |
| 2026-10-07 | $30.38 | $45,301,364,163 | 17 / 11 |
| 2026-10-08 | $30.39 | $45,261,858,863 | 17 / 11 |
| 2026-10-09 | $30.42 | $45,261,858,864 | 17 / 12 |
| 2026-10-10 | $30.47 | $45,319,123,316 | 17 / 12 |
| 2026-10-11 | $30.47 | $45,319,123,316 | 17 / 12 |
| 2026-10-12 | $30.47 | $45,319,123,316 | 17 / 12 |
| 2026-10-13 | $30.51 | $45,301,133,593 | 17 / 11 |
| 2026-10-14 | $30.51 | $45,301,133,593 | 17 / 10 |
| 2026-10-15 | $30.51 | $45,301,133,593 | 17 / 10 |
| 2026-10-16 | $30.51 | $45,301,133,593 | 17 / 10 |
| 2026-10-17 | $30.51 | $45,301,133,593 | 17 / 10 |
| 2026-10-18 | $30.75 | $45,141,478,739 | 17 / 12 |
| 2026-10-19 | $30.75 | $45,141,478,739 | 17 / 12 |
| 2026-10-20 | $30.87 | $44,940,607,867 | 17 / 12 |
| 2026-10-21 | $30.87 | $44,940,607,867 | 17 / 12 |
| 2026-10-22 | $30.92 | $44,940,607,867 | 17 / 12 |
| 2026-10-23 | $30.93 | $44,940,607,867 | 17 / 12 |
| 2026-10-24 | $31.01 | $44,905,441,200 | 17 / 12 |
| 2026-10-25 | $31.01 | $44,905,441,200 | 17 / 11 |
| 2026-10-26 | $31.01 | $44,905,441,200 | 17 / 11 |
| 2026-10-27 | $31.01 | $44,905,441,200 | 17 / 11 |
| 2026-10-28 | $31.02 | $44,852,691,200 | 17 / 11 |
| 2026-10-29 | $31.02 | $44,852,691,200 | 17 / 11 |
| 2026-10-30 | $31.02 | $44,852,691,200 | 17 / 11 |
| 2026-10-31 | $31.02 | $44,852,691,200 | 17 / 11 |
| 2026-11-01 | $31.02 | $44,852,691,200 | 17 / 11 |
| 2026-11-02 | $31.02 | $44,852,691,200 | 17 / 11 |
| 2026-11-03 | $31.02 | $44,852,691,200 | 17 / 11 |
| 2026-11-04 | $31.02 | $44,852,691,200 | 17 / 11 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 6 Buy / Strong Buy · 17 Hold · 6 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 13 recorded
1 raises · 0 cuts · 0 unchanged · 2 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.